Market revenue in 2023 | USD 197.1 million |
Market revenue in 2030 | USD 339.8 million |
Growth rate | 8.1% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Service |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Service |
Key market players worldwide | Agilent Technologies Inc, Illumina Inc, Qiagen NV, Thermo Fisher Scientific Inc, Roche, ARUP Laboratories, Abbott Laboratories, Myriad Genetics Inc, BioMerieux SA |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oncology companion diagnostic market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 66.46% in 2023. Horizon Databook has segmented the Middle East & Africa oncology companion diagnostic market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.
MEA is expected to witness significant growth opportunities, as the majority of market is untapped due to the absence of structured cancer screening programs in underdeveloped African economies has impeded early detection efforts. However, recent initiatives in countries such as Morocco, the UAE, and South Africa have led to the organization of cancer screening programs.
Collaborative efforts between companies and government institutions to supply these tests are expected to drive market growth. These initiatives are anticipated to boost the development of new cancer detection tests. Despite the promise of novel tests such as liquid biopsy, their high cost and the shortage of skilled professionals to administer them pose significant challenges.
However, in June 2023, the Qatar government launched the new Qatar Cancer Plan 2023-2026, which aims to enhance cancer care and establish Qatar as a regional leader. Developed with key stakeholders and WHO experts, the plan covers prevention, early detection, diagnosis, treatment, and palliative care.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa oncology companion diagnostic market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa oncology companion diagnostic market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account